CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy: treatment effect in hereditary vs. wild-type disease

17 May 2025 (12:03 - 12:11)
Organised by: Logo
Add to my library
Congress Presentation Part of: Hottest trials and trial updates (1) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo

University College London, London (United Kingdom of Great Britain & Northern Ireland)

The Event

Event poster

Heart Failure 2025

17 May 2025 12:03 CET